These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 26891143)
1. An overview of pharmaceutical patent litigation in China. Carver T Pharm Pat Anal; 2016; 5(2):75-7. PubMed ID: 26891143 [No Abstract] [Full Text] [Related]
2. Pharmaceutical patent law: the Canadian perspective. Aumand L; Norman J Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187 [TBL] [Abstract][Full Text] [Related]
3. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
4. Patent litigation in India continues to throw up new challenges. Reddy Thikkavarapu P Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790 [TBL] [Abstract][Full Text] [Related]
5. The ITC as an attractive patent litigation forum for the biotechnology and pharmaceutical industry. Burton CA; Margonis LE Pharm Pat Anal; 2013 Mar; 2(2):177-80. PubMed ID: 24237023 [No Abstract] [Full Text] [Related]
6. Korea: the new first battleground for the high stakes poker game of pharmaceutical patent litigation. Choe JY; Yoon KA; Lee S Pharm Pat Anal; 2015; 4(6):409-13. PubMed ID: 26580988 [No Abstract] [Full Text] [Related]
7. Patenting pharmaceuticals in China. Han W; Luo J Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759 [TBL] [Abstract][Full Text] [Related]
8. Patent fights rumble in China. Howard K Nat Rev Drug Discov; 2004 Dec; 3(12):988-9. PubMed ID: 15645601 [No Abstract] [Full Text] [Related]
9. How would patent reform legislation in the United States impact the pharmaceutical industry? Williams AW Expert Opin Ther Pat; 2015 Feb; 25(2):131-3. PubMed ID: 25387953 [TBL] [Abstract][Full Text] [Related]
10. Compulsory licenses as a defense in pharmaceutical and biotech patent litigation. von Falck A Pharm Pat Anal; 2016 Sep; 5(6):351-353. PubMed ID: 27805479 [No Abstract] [Full Text] [Related]
11. What is holding up the Unified Patent Court? Cohen L; Johnson A Pharm Pat Anal; 2018 Sep; 7(5):187-192. PubMed ID: 30101657 [TBL] [Abstract][Full Text] [Related]
12. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act. Genieser LH; McCann CE Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880 [TBL] [Abstract][Full Text] [Related]
13. Preliminary injunctions in generic and branded patent litigation. Cohen S; England P Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903 [No Abstract] [Full Text] [Related]
14. Pharmaceutical patent law: expert perspectives from around the globe. Komatani TS Pharm Pat Anal; 2016 Jul; 5(4):195-7. PubMed ID: 27409277 [No Abstract] [Full Text] [Related]
15. Will changes to patent infringements attract drug research in the UK? Snodin M Expert Opin Ther Pat; 2015; 25(9):949-51. PubMed ID: 25813963 [TBL] [Abstract][Full Text] [Related]
16. Analyzing the protection scope limit for biosequence patent claims in China. Li W Nat Biotechnol; 2018 Sep; 36(9):811-813. PubMed ID: 30188533 [No Abstract] [Full Text] [Related]
17. Update on Brazil's pharma patent landscape. Gosain R Pharm Pat Anal; 2016 Sep; 5(6):385-390. PubMed ID: 27804784 [TBL] [Abstract][Full Text] [Related]
18. The consequences of 'double examination' for pharmaceutical patent applications in Brazil. Salerno G Pharm Pat Anal; 2017 Mar; 6(2):49-51. PubMed ID: 28274178 [No Abstract] [Full Text] [Related]
19. Patent watch: Progress in three key patent disputes in 2009. Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395 [No Abstract] [Full Text] [Related]
20. The extraterritoriality of US patents on the pharmaceutical industry. Park H Pharm Pat Anal; 2014 Sep; 3(5):491-8. PubMed ID: 25374318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]